longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Artelo Biosciences(ARTL.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·05/18/2026 20:05
US
GOSS
-6.69%
US
LTRN
+4.73%
US
AIM
-3.79%
benzinga_article·05/18/2026 20:05
US
GOSS
-6.69%
US
LTRN
+4.73%
US
AIM
-3.79%

Artelo Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results.

benzinga_article·05/15/2026 23:16
US
ARTL
-6.34%
US
BBH
+0.64%
US
IBB
+0.68%
benzinga_article·05/15/2026 23:16
US
ARTL
-6.34%
US
BBH
+0.64%
US
IBB
+0.68%

Artelo Biosciences | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/15/2026 04:17
US
ARTL
-6.34%
Earnings Watch·05/15/2026 04:17
US
ARTL
-6.34%

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development | ARTL Stock News

StockTitan·04/28/2026 12:25
US
ARTL
-6.34%
US
LABU
+2.48%
StockTitan·04/28/2026 12:25
US
ARTL
-6.34%
US
LABU
+2.48%

What's Behind The Rise In Artelo Biosciences Stock?

Fidelity·04/21/2026 00:06
US
ARTL
-6.34%
US
IBB
+0.68%
US
BBH
+0.64%
Fidelity·04/21/2026 00:06
US
ARTL
-6.34%
US
IBB
+0.68%
US
BBH
+0.64%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Artelo Biosciences released FY2026 Q1 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -4.0027 (forecast USD -0.78)
03:00
Feb25
Artelo Biosciences released FY2025 earnings on February 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -37.5481 (forecast USD -36.33)
04:00
Artelo Biosciences released FY2025 Q4 earnings on February 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -6.181 (forecast USD -4.71)
04:00
Nov13
Artelo Biosciences released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -41.7408
04:00
Artelo Biosciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.97 (forecast USD -0.82)
04:00
Sep9
Nasdaq-listed Artelo Biosciences Completes $3 Million Rights Offering
08:22

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -2.958 M, EPS -4.0027

Mar10
Reverse Stock Split(EST)

1-for-3 Reverse Stock Split

Feb24
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -4.166 M, EPS -6.181

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
NCPL
0.8200
+80.66%
+0.366
ATPC
3.590
+71.77%
+1.500
QBTX
19.880
+66.50%
+7.940
AKAN
23.460
+61.68%
+8.950
RGTX
29.100
+60.95%
+11.020
PCLA
2.250
+60.70%
+0.850
RGTU
29.300
+60.20%
+11.010
CODX
3.710
+55.23%
+1.320
AMPGR
0.8677
+54.95%
+0.308
NIVF
1.120
+51.54%
+0.381
View More